Evidence map›Paper›PMID 25033426›Full record

ArticlePloS one2014

Synergistic up-regulation of CXCL10 by virus and IFN γ in human airway epithelial cells.

Karen L Oslund, Xu Zhou, Boram Lee, Lingxiang Zhu, Trang Duong, Robert Shih, Nicole Baumgarth, Li-Yin Hung, Reen Wu, Yin Chen

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon.American journal of physiology. Gastrointestinal and liver physiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karen L OslundCenter for Comparative Respiratory Biology and Medicine, Department of Internal Medicine, University of California Davis, Davis, California, United States of America; Department of Pathology, Immunology and Microbiology, School of Veterinary Medicine, University of California, Davis, Davis, California, United States of America.
Xu ZhouDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, United States of America.
Boram LeeDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, United States of America.
Lingxiang ZhuDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, United States of America.
Trang DuongCenter for Comparative Respiratory Biology and Medicine, Department of Internal Medicine, University of California Davis, Davis, California, United States of America; Department of Pathology, Immunology and Microbiology, School of Veterinary Medicine, University of California, Davis, Davis, California, United States of America.
Robert ShihCenter for Comparative Respiratory Biology and Medicine, Department of Internal Medicine, University of California Davis, Davis, California, United States of America.
Nicole BaumgarthDepartment of Pathology, Immunology and Microbiology, School of Veterinary Medicine, University of California, Davis, Davis, California, United States of America.
Li-Yin HungCenter for Comparative Respiratory Biology and Medicine, Department of Internal Medicine, University of California Davis, Davis, California, United States of America.
Reen WuCenter for Comparative Respiratory Biology and Medicine, Department of Internal Medicine, University of California Davis, Davis, California, United States of America.
Yin ChenDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, United States of America.

Funding

ROLE OF EPITHELIAL CELLS IN OZONE-NITROGEN DIOXIDE INTERACTIONP01ES000628 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI WU, REEN · 1985 to 2010
$12.5M
Roles of IL-17-induced gene expression in airway epithelial host defenseR01HL077902 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI WU, REEN · 2005 to 2013
$2.8M
Regulation of MUC19 by Th2 cytokine in airway epitheliumR01AI061695 · NIAID · UNIVERSITY OF ARIZONA · PI CHEN, YIN · 2007 to 2011
$1.9M
Regulation of Airway Mucin Gene Expression by Epigenetic MechanismR01HL096373 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WU, REEN · 2010 to 2013
$1.5M
Programming Airway Epithelial Differentiation by RadR01HL077315 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI WU, REEN · 2004 to 2008
$1.4M
Thioredoxin in Neutrophil-Airway Epithelial InteractionsK08ES012441 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI OSLUND, KAREN L · 2004 to 2008
$620k
TLR3, TICAM1 and human rhinovirus infectionR21AI113526 · NIAID · UNIVERSITY OF ARIZONA · PI CHEN, YIN · 2014 to 2015
$417k
NHLBI NIH HHS R01 HL077315NHLBI NIH HHS R01 HL077902NHLBI NIH HHS R01 HL096373NIAID NIH HHS R01 AI061695NIAID NIH HHS R21 AI113526NIEHS NIH HHS K08 ES012441NIEHS NIH HHS P01 ES000628NIEHS NIH HHS R01 ES00628
6 · The paper itself

Abstract

Airway epithelial cells are the first line of defense against viral infections and are instrumental in coordinating the inflammatory response. In this study, we demonstrate the synergistic stimulation of CXCL10 mRNA and protein, a key chemokine responsible for the early immune response to viral infection, following treatment of airway epithelial cells with IFN γ and influenza virus. The synergism also occurred when the cells were treated with IFN γ and a viral replication mimicker (dsRNA) both in vitro and in vivo. Despite the requirement of type I interferon (IFNAR) signaling in dsRNA-induced CXCL10, the synergism was independent of the IFNAR pathway since it wasn't affected by the addition of a neutralizing IFNAR antibody or the complete lack of IFNAR expression. Furthermore, the same synergistic effect was also observed when a CXCL10 promoter reporter was examined. Although the responsive promoter region contains both ISRE and NFκB sites, western blot analysis indicated that the combined treatment of IFN γ and dsRNA significantly augmented NFκB but not STAT1 activation as compared to the single treatment. Therefore, we conclude that IFN γ and dsRNA act in concert to potentiate CXCL10 expression in airway epithelial cells via an NFκB-dependent but IFNAR-STAT independent pathway and it is at least partly regulated at the transcriptional level.

Indexed as

AnimalsCells, CulturedChemokine CXCL10Enzyme ActivationEpithelial CellsHumansInfluenza A virusInfluenza, HumanInterferon-gammaInterferon Type IMiceMice, Inbred BALB CNF-kappa BPromoter Regions, GeneticRespiratory MucosaRNA, Double-StrandedChemokine CXCL10CXCL10 protein, humanInterferon-gammaInterferon Type INF-kappa BRNA, Double-StrandedRNA, MessengerSTAT1 protein, humanSTAT1 Transcription Factor

Identifiers

PMID25033426
PMCPMC4102466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.